Jonathan Jay Mazelsky
Known title: DirectorCIK: 0001556270
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 11, 2026
XRAY: Earnings, Target Cut, Expansion, Medicare Coverage. XRAY reported its Q2 earnings, prompting analysts to review the company’s outlook. Piper Sandler lowered its target to $12, citing the reset strategy after a new Midwest dental partnership. Meanwhile, the Wellspect unit announced Medicare reimbursement for its Surity urinary portfolio, expanding the company’s product reach. These developments add new layers to XRAY’s growth narrative.
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
KeyBanc initiates IDEXX coverage with Sector Weight rating. KeyBanc has started covering IDEXX Laboratories, assigning it a Sector Weight rating. This move adds to analyst attention as investors look ahead to the company's upcoming Q3 2026 earnings report. The stock is currently trading near its 52-week high, reflecting strong recent performance.
Transaction History
| PODD | ▲ Buy | Grant | 141 | $18K | 9/30/2026 | View on chart |
| PODD | ▲ Buy | Grant | 1,355 | $0 | 7/1/2026 | View on chart |
| XRAY | ▲ Buy | Grant | 10,000 | $101K | 6/12/2026 | View on chart |
| XRAY | ▲ Buy | Grant | 22,822 | $0 | 6/3/2026 | View on chart |
| IDXX | ▲ Buy | Option Exercise | 197 | $100K | 2/27/2026 | View on chart |
| IDXX | ▲ Buy | Option Exercise | 23,326 | $3.3M | 2/26/2026 | View on chart |
| IDXX | ▼ Sell | Open Market | 1,281 | $834K | 2/26/2026 | View on chart |
| IDXX | ▼ Sell | Open Market | 1,095 | $713K | 2/26/2026 | View on chart |
| IDXX | ▼ Sell | Open Market | 1,669 | $1.1M | 2/26/2026 | View on chart |
| IDXX | ▼ Sell | Open Market | 1,171 | $765K | 2/26/2026 | View on chart |
| IDXX | ▼ Sell | Open Market | 1,111 | $727K | 2/26/2026 | View on chart |
| IDXX | ▼ Sell | Open Market | 1,488 | $976K | 2/26/2026 | View on chart |
| IDXX | ▼ Sell | Open Market | 1,343 | $882K | 2/26/2026 | View on chart |
| IDXX | ▼ Sell | Open Market | 2,860 | $1.9M | 2/26/2026 | View on chart |
| IDXX | ▼ Sell | Open Market | 3,660 | $2.4M | 2/26/2026 | View on chart |
| IDXX | ▼ Sell | Open Market | 2,859 | $1.9M | 2/26/2026 | View on chart |
| IDXX | ▼ Sell | Open Market | 1,200 | $793K | 2/26/2026 | View on chart |
| IDXX | ▼ Sell | Open Market | 1,000 | $662K | 2/26/2026 | View on chart |
| IDXX | ▼ Sell | Open Market | 2,589 | $1.7M | 2/26/2026 | View on chart |
| IDXX | ▲ Buy | Option Exercise | 958 | $0 | 2/14/2026 | View on chart |
| IDXX | ▲ Buy | Option Exercise | 1,099 | $0 | 2/14/2026 | View on chart |
| IDXX | ▼ Sell | Tax Withholding | 915 | $576K | 2/14/2026 | View on chart |
| XRAY | ▲ Buy | Grant | 395 | $0 | 1/9/2026 | View on chart |
| XRAY | ▲ Buy | Grant | 360 | $0 | 10/10/2025 | View on chart |
| IDXX | ▼ Sell | Gift | 1,051 | $0 | 8/15/2025 | View on chart |
| IDXX | ▲ Buy | Option Exercise | 183 | $110K | 8/8/2025 | View on chart |
| IDXX | ▼ Sell | Open Market | 1,095 | $686K | 8/6/2025 | View on chart |
| IDXX | ▼ Sell | Open Market | 3,000 | $1.9M | 8/6/2025 | View on chart |
| IDXX | ▼ Sell | Open Market | 1,525 | $958K | 8/6/2025 | View on chart |
| IDXX | ▼ Sell | Open Market | 1,822 | $1.2M | 8/6/2025 | View on chart |
| IDXX | ▼ Sell | Open Market | 3,397 | $2.1M | 8/6/2025 | View on chart |
| IDXX | ▼ Sell | Open Market | 7,299 | $4.6M | 8/6/2025 | View on chart |
| IDXX | ▼ Sell | Open Market | 6,056 | $3.8M | 8/6/2025 | View on chart |
| IDXX | ▲ Buy | Option Exercise | 29,260 | $2.0M | 8/6/2025 | View on chart |
| IDXX | ▼ Sell | Open Market | 3,526 | $2.2M | 8/6/2025 | View on chart |
| IDXX | ▼ Sell | Open Market | 880 | $560K | 8/6/2025 | View on chart |
| IDXX | ▼ Sell | Open Market | 660 | $422K | 8/6/2025 | View on chart |
| XRAY | ▲ Buy | Grant | 279 | $0 | 7/11/2025 | View on chart |
| XRAY | ▲ Buy | Grant | 13,880 | $0 | 5/22/2025 | View on chart |
| XRAY | ▲ Buy | Grant | 148 | $0 | 4/11/2025 | View on chart |
| IDXX | ▲ Buy | Option Exercise | 689 | $0 | 2/14/2025 | View on chart |
| IDXX | ▲ Buy | Option Exercise | 958 | $0 | 2/14/2025 | View on chart |
| IDXX | ▲ Buy | Option Exercise | 1,100 | $0 | 2/14/2025 | View on chart |
| IDXX | ▼ Sell | Tax Withholding | 1,222 | $543K | 2/14/2025 | View on chart |
| XRAY | ▲ Buy | Grant | 115 | $0 | 1/10/2025 | View on chart |
| XRAY | ▲ Buy | Grant | 80 | $0 | 10/11/2024 | View on chart |
| IDXX | ▲ Buy | Option Exercise | 384 | $0 | 8/5/2024 | View on chart |
| IDXX | ▼ Sell | Tax Withholding | 170 | $77K | 8/5/2024 | View on chart |
| XRAY | ▲ Buy | Grant | 87 | $0 | 7/12/2024 | View on chart |
| XRAY | ▲ Buy | Grant | 7,994 | $0 | 5/23/2024 | View on chart |
| XRAY | ▲ Buy | Grant | 26 | $0 | 4/12/2024 | View on chart |
| IDXX | ▼ Sell | Gift | 550 | $0 | 2/29/2024 | View on chart |
| IDXX | ▲ Buy | Option Exercise | 483 | $100K | 2/21/2024 | View on chart |
| IDXX | ▲ Buy | Option Exercise | 435 | $0 | 2/14/2024 | View on chart |
| IDXX | ▲ Buy | Option Exercise | 974 | $0 | 2/14/2024 | View on chart |
| IDXX | ▲ Buy | Option Exercise | 689 | $0 | 2/14/2024 | View on chart |
| IDXX | ▲ Buy | Option Exercise | 958 | $0 | 2/14/2024 | View on chart |
| IDXX | ▲ Buy | Option Exercise | 1,100 | $0 | 2/14/2024 | View on chart |
| IDXX | ▼ Sell | Tax Withholding | 1,839 | $1.0M | 2/14/2024 | View on chart |
| IDXX | ▼ Sell | Open Market | 462 | $265K | 2/7/2024 | View on chart |
| IDXX | ▼ Sell | Open Market | 4,124 | $2.4M | 2/7/2024 | View on chart |
| IDXX | ▼ Sell | Open Market | 1,353 | $778K | 2/7/2024 | View on chart |
| IDXX | ▼ Sell | Open Market | 705 | $406K | 2/7/2024 | View on chart |
| IDXX | ▲ Buy | Option Exercise | 12,000 | $814K | 2/7/2024 | View on chart |
| IDXX | ▼ Sell | Open Market | 5,356 | $3.1M | 2/7/2024 | View on chart |
| XRAY | ▲ Buy | Grant | 21 | $0 | 1/12/2024 | View on chart |
| IDXX | ▼ Sell | Open Market | 5,804 | $3.0M | 12/4/2023 | View on chart |
| IDXX | ▼ Sell | Open Market | 1,324 | $680K | 12/4/2023 | View on chart |
| IDXX | ▲ Buy | Option Exercise | 13,424 | $1.1M | 12/4/2023 | View on chart |
| XRAY | ▲ Buy | Grant | 22 | $0 | 10/13/2023 | View on chart |
| IDXX | ▲ Buy | Option Exercise | 13,424 | $1.1M | 8/31/2023 | View on chart |
| IDXX | ▼ Sell | Open Market | 13,424 | $6.9M | 8/31/2023 | View on chart |
| IDXX | ▲ Buy | Option Exercise | 384 | $0 | 8/5/2023 | View on chart |
| IDXX | ▼ Sell | Tax Withholding | 170 | $86K | 8/5/2023 | View on chart |
| XRAY | ▲ Buy | Grant | 19 | $0 | 7/14/2023 | View on chart |
| XRAY | ▲ Buy | Grant | 5,419 | $0 | 5/25/2023 | View on chart |
| IDXX | ▼ Sell | Gift | 602 | $0 | 5/18/2023 | View on chart |
| IDXX | ▲ Buy | Option Exercise | 560 | $100K | 5/4/2023 | View on chart |
| IDXX | ▲ Buy | Option Exercise | 504 | $0 | 2/14/2023 | View on chart |
| IDXX | ▲ Buy | Option Exercise | 435 | $0 | 2/14/2023 | View on chart |
| IDXX | ▲ Buy | Option Exercise | 689 | $0 | 2/14/2023 | View on chart |
| IDXX | ▲ Buy | Option Exercise | 974 | $0 | 2/14/2023 | View on chart |
| IDXX | ▲ Buy | Option Exercise | 959 | $0 | 2/14/2023 | View on chart |
| IDXX | ▼ Sell | Tax Withholding | 1,657 | $835K | 2/14/2023 | View on chart |
| IDXX | ▲ Buy | Option Exercise | 18,998 | $1.2M | 11/14/2022 | View on chart |
| IDXX | ▼ Sell | Open Market | 972 | $421K | 11/14/2022 | View on chart |
| IDXX | ▼ Sell | Open Market | 6,385 | $2.8M | 11/14/2022 | View on chart |
| IDXX | ▼ Sell | Open Market | 2,543 | $1.1M | 11/14/2022 | View on chart |
| IDXX | ▼ Sell | Open Market | 600 | $262K | 11/14/2022 | View on chart |
| IDXX | ▼ Sell | Open Market | 3,704 | $1.4M | 11/7/2022 | View on chart |
| IDXX | ▲ Buy | Option Exercise | 24,002 | $1.2M | 11/7/2022 | View on chart |
| IDXX | ▼ Sell | Open Market | 900 | $341K | 11/7/2022 | View on chart |
| IDXX | ▼ Sell | Open Market | 500 | $190K | 11/7/2022 | View on chart |
| IDXX | ▼ Sell | Open Market | 2,716 | $1.0M | 11/7/2022 | View on chart |
| IDXX | ▼ Sell | Open Market | 3,018 | $1.2M | 11/7/2022 | View on chart |
| IDXX | ▼ Sell | Open Market | 392 | $151K | 11/7/2022 | View on chart |
| IDXX | ▼ Sell | Open Market | 2,000 | $759K | 11/7/2022 | View on chart |
| IDXX | ▲ Buy | Option Exercise | 385 | $0 | 8/5/2022 | View on chart |
| IDXX | ▼ Sell | Tax Withholding | 179 | $73K | 8/5/2022 | View on chart |
| IDXX | ▲ Buy | Option Exercise | 706 | $100K | 5/20/2022 | View on chart |
| IDXX | ▼ Sell | Gift | 500 | $0 | 3/4/2022 | View on chart |
| IDXX | ▲ Buy | Option Exercise | 459 | $0 | 2/14/2022 | View on chart |
| IDXX | ▲ Buy | Option Exercise | 505 | $0 | 2/14/2022 | View on chart |
| IDXX | ▲ Buy | Option Exercise | 435 | $0 | 2/14/2022 | View on chart |
| IDXX | ▲ Buy | Option Exercise | 974 | $0 | 2/14/2022 | View on chart |
| IDXX | ▲ Buy | Option Exercise | 690 | $0 | 2/14/2022 | View on chart |
| IDXX | ▼ Sell | Tax Withholding | 1,423 | $719K | 2/14/2022 | View on chart |
| IDXX | ▼ Sell | Open Market | 533 | $358K | 8/16/2021 | View on chart |
| IDXX | ▼ Sell | Open Market | 488 | $329K | 8/16/2021 | View on chart |
| IDXX | ▼ Sell | Open Market | 182 | $123K | 8/16/2021 | View on chart |
| IDXX | ▼ Sell | Open Market | 60 | $41K | 8/16/2021 | View on chart |
| IDXX | ▼ Sell | Open Market | 3,417 | $2.3M | 8/13/2021 | View on chart |
| IDXX | ▼ Sell | Open Market | 983 | $665K | 8/13/2021 | View on chart |
| IDXX | ▼ Sell | Open Market | 337 | $228K | 8/13/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 4, 2026
Insulet Sets Q3 2026 Earnings Date for Nov 4
Insulet has scheduled its third-quarter 2026 financial results for release on November 4, 2026. Recent commentary suggests the company offers affordable growth supported by strong fundamentals. The stock is currently trading near its 52-week low, with technical indicators showing a support rejection and volume spike.
Insulet Sets Q3 2026 Earnings Date for Nov 4. Insulet has scheduled its third-quarter 2026 financial results for release on November 4, 2026. Recent commentary suggests the company offers affordable growth supported by strong fundamentals. The stock is currently trading near its 52-week low, with technical indicators showing a support rejection and volume spike.